文献速递腹部技术与安全CTMR

盆腔CT在胆道癌术后患者监测中的作用

Role of pelvic CT during surveillance of patients with resected biliary tract cancer.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

研究纳入2004至2018年在密歇根大学接受R0或R1切除的151例胆道癌患者,由两名放射科医生独立将腹盆腔CT和MRI报告分级为阳性、不确定或阴性,第三名盲法放射科医生复核所有阳性和不确定扫描。中位随访19.2个月,仅1例(0%)发生孤立性盆腔转移(95% CI 0.004-0.1;p = 0.0003),作者认为无特定症状时随访盆腔CT可能不必要。

要点

  • 胆道癌术后监测中孤立性盆腔转移罕见,151例中仅1例(0%)为孤立性骨性盆腔转移(95% CI 0.004-0.1)。
  • 23例(15%)出现腹部和盆腔同时转移,51例(34%)为局限性上腹部转移,123例(81%)无盆腔转移。
  • 3例(2%)出现孤立性单纯性腹水(不确定级)而无同期上腹部转移。

核心结论

  • 胆道癌术后监测期间孤立性盆腔转移罕见,因此无特定症状时随访盆腔CT可能不必要。

研究设计与样本

  • 回顾性研究,纳入2004至2018年在密歇根大学接受R0或R1手术切除的151例18岁以上胆道癌患者,要求至少6个月无病监测期。
  • 由两名放射科医生独立将腹部和盆腔CT及MRI报告分别分级为阳性(器官转移、腹膜癌病或淋巴结增大)、不确定(边缘性淋巴结或非结节性腹水)或阴性(无异常或良性发现),第三名盲法放射科医生复核所有阳性和不确定扫描。
  • 通过查阅临床记录识别需要提前进行盆腔监测扫描的新发或加重症状体征;采用95%二项比例置信区间计算孤立性盆腔转移概率。

关键影像表现/征象

  • 胆道癌解剖分类为肝外(远端和肝门)胆管癌38例(25%)、肝内胆管癌57例(38%)和胆囊癌56例(37%)。
  • 123例(81%)无盆腔转移,51例(34%)有局限性上腹部转移,23例(15%)有腹部和盆腔同时转移。
  • 1例(0%)肝内胆管癌切除患者在监测期间发生孤立性骨性盆腔转移(95% CI 0.004-0.1;p = 0.0003)。
  • 3例(2%)出现孤立性单纯性腹水(不确定级)而无同期上腹部转移。

诊断标准与关键数值

  • 影像报告分级标准:阳性为器官转移、腹膜癌病或淋巴结增大;不确定为边缘性淋巴结或非结节性腹水;阴性为无异常或良性发现,腹部和盆腔分别评定。

临床应用与阅片要点

  • 作者认为,胆道癌术后监测中孤立性盆腔转移罕见,无特定症状时随访盆腔CT可能不必要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The aim of the study was to identify the frequency of isolated pelvic metastasis with the goal of determining the utility of pelvic CT as a surveillance strategy in patients with resected biliary tract cancer (BTC).

METHODS: Study eligibility criteria included patients 18 years or older with BTC who underwent R0 or R1 surgical resection at University of Michigan between 2004 and 2018, with a minimum 6-month disease-free surveillance period. CT and MRI reports were independently graded by two radiologists as positive (organ metastasis, peritoneal carcinomatosis, or enlarged lymph nodes), equivocal (borderline lymph nodes or non-nodular ascites), or negative (absence of or benign findings) in the abdomen and pelvis separately. A 3rd blinded radiologist reviewed all positive and equivocal scans. Clinic notes were reviewed to identify new or worsening signs and symptoms that would warrant an earlier pelvic surveillance scan. A 95% binomial proportion confidence interval was used to find the probability of isolated pelvic metastasis.

RESULTS: BTC were anatomically classified as extra-hepatic (distal and hilar) cholangiocarcinoma (38; 25%), intra-hepatic cholangiocarcinoma (57; 38%), and gallbladder cancer (56; 37%). 151 patients met eligibility criteria, of which 123 (81%) had no pelvic metastasis, 51 (34%) had localized upper abdominal metastasis, and 23 (15%) had concomitant abdominal and pelvic metastasis. Median follow-up time was 19.2 months. One (0%) subject with resected BTC (intra-hepatic) developed isolated osseous pelvic metastasis during surveillance (95% CI 0.004-0.1; p = 0.0003). 3 (2%) subjects developed isolated simple ascites (equivocal grade) without concurrent upper abdominal metastasis.

CONCLUSION: Isolated pelvic metastasis is a rare occurrence during surveillance in patients with resected BTCs, and therefore, follow-up pelvic CT in absence of specific symptoms may be unnecessary.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Aslam A, Mendiratta-Lala M, Curci NE, et al. Role of pelvic CT during surveillance of patients with resected biliary tract cancer. Abdom Radiol (NY). 2020. PMID: 31385009. doi:10.1007/s00261-019-02159-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。